Randox Life Sciences produce highly sensitive antibodies to a range of Drugs of Abuse targets

PRLog (Press Release) - Jun. 28, 2011 - Randox specific life science products are manufactured at our ISO 13485 certified manufacturing plant in the United Kingdom using state of the art facilities.It is now accepted that drug misuse is a large and growing problem affecting not only the user but society as a whole. Drug testing can provide a tool for detecting users and monitoring the compliance of subjects in recovery programs.  Randox Life Sciences has developed an extensive range of drug targeted antibodies for research and development applications. Our high quality, cost effective antibodies and conjugates are specific to a range of Drugs of Abuse targets including Antidepressants, Barbiturates, Benzodiazepines, Hallucinogens, Opiates, Sedatives, Stimulants and Therapeutic Drugs.

Randox Life Sciences are continually developing antibodies to new Drugs of Abuse targets. We have recently released a range of drug targeted antibodies including Anti-Haloperidol, Anti-Methicathinone, Anti-Norfentanyl and therapeutic antibody Anti-Theophylline suitable for use in the development of in-house detection methods such as ELISA. Our antibodies have corresponding HRP conjugates (tracers) available free for a limited time only with each order.

For more information please visit http://www.randox-lifesciences.com or email lifesciences@randox.com.

About Randox  
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.

# # #

Randox Laboratories are market leaders in the diagnostics field. The range of products includes, Biochip Array Technology, clinical chemistry analysers and reagents, quality control materials and an extensive life science portfolio.